Till Finansinspektionens startsida

Börsinformation

IssuerCalliditas Therapeutics AB


Holder
Mark Lampert

Instrument
InstrumentShares and call options
Before the transaction
SharesData not given*
Voting rightsData not given*
Transaction
Reason for major shareholding notificationBuy
Date03/07/2019
Limit for number of shares5 %
Limit for number of votes5 %
After the transaction
Quantity
Shares1,866,000
Directly held voting rights0
Indirectly held voting rights1,866,000
Percentage
Directly held shares4.82075 %
Directly held voting rights0 %
Indirectly held voting rights4.82075 %
 
Resulting distribution of total holdings
Percentage of voting rights: Number of underlying shares:
Shares 4.82075 %1,866,000
Instruments - FITA Ch. 4, section 2, first paragraph, line 2 2.84182 %1,100,000
Instruments - FITA Ch. 4, section 2, first paragraph, line 3
 -  Physically settled  
 -  Cash settled  
   
Total 7.66257 %2,966,000
 

Chain of controlling companies
Voting rights% Voting rightsCompany
1,445,4383.73424Biotechnology Value Fund, L.P.
1,214,3643.13727Biotechnology Value Fund II, L.P.
208,4410.5385Biotechnology Value Trading Fund OS, L.P.
97,7570.25255MSI BVF SPV, L.L.C.
Group total holdings
Voting rights2,966,000
Percentage of voting rights7.66257
Notes (other relevant informations according to law)
The notification is based on the total number of outstanding shares/votes in Calliditas Therapeutics AB following the issuance of 3,505,291 new shares, which was announced on 3 July 2019. If calculated on the number of outstanding shares/votes prior to the aforementioned issuance of new shares, Mark Lampert indirectly owns 8.42557% of the shares/votes. The call options can be exercised during the period 2 July 2019 – 2 July 2022.

Published
05/07/2019 10:17
Contact
NameJames Kratky
Phone**** Email**** 
*)Note that neither phone nor email is published on fi.se

The legal basis for FI to compile and publish these so-called major shareholding notification announcements is that this document is necessary for FI to carry out a task in the public interest (Article 6(1)(e) of the General Data Protection Regulation). Chapter 4 of Act (1991:980) sets forth that major shareholders are obligated under certain conditions to notify FI when buying or selling shares and that FI must disclose this information. Chapter 12, sections 10–11 of FFFS 2007:17 specifies the required content of the major shareholding notification. Read more about FI’s processing of personal data here www.fi.se/sv/om-fi/dataskydd-och-behandling-av-personuppgifter-pa-fi/

*Source of information has chosen not to submit the data
 
rapportering@fi.se
Tfn 08-408 980 37
Fax 08-24 39 25